CoChat
Cited by 212

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Prevalence and Treatment Patterns of Autism Spectrum Disorder in the United States, 2016

Open access
Xu, Guifeng, Strathearn, Lane, Liu, Buyun, O’Brien, Matthew, Kopelman, Todd G., Zhu, Jing, Snetselaar, Linda G., Bao, Wei · 2019 · JAMA Pediatrics

Abstract

Importance: Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder. Previous surveys have reported a steady increase in ASD prevalence in US children over the past decades. Several behavioral therapies and medications have been developed to treat the symptoms of ASD; however, little is known about the current status of treatment usage for children diagnosed as having ASD. Objective: To estimate the prevalence and treatment patterns of ASD among US children using nationally representative data. Design, Setting, and Participants: This study used data from the 2016 National Survey of Children's Health, a nationwide, population-based, cross-sectional survey. We included 43 032 children aged 3 to 17 years. Data were collected through questionnaires completed by a parent or guardian. Data were analyzed from February 2018 to March 2018. Main Outcomes and Measures: Outcome variables included ASD diagnosed by a physician or health professional and the use of behavioral treatment or medication treatment among children with ASD. Results: Of the 43 032 included participants, 22 072 (51.3%) were male, and the mean (SD) age was 10.7 (4.4) years. The weighted prevalence of ever-diagnosed ASD and current ASD were 2.79% (95% CI, 2.46-3.12) and 2.50% (95% CI, 2.21-2.79), respectively. The state-level prevalence of ever-diagnosed ASD varied from 1.54% (95% CI, 0.60-2.48) in Texas to 4.88% (95% CI, 2.72-7.05) in Florida. Nationally, about 70% of children with current ASD (70.5%; 95% CI, 65.1-75.8) were treated; 43.3% (95% CI, 37.4-49.2) received behavioral treatment only, 6.9% (95% CI, 3.7-10.1) received medication treatment only, and 20.3% (95% CI, 16.5-24.1) received both behavioral and medication treatments. The remaining 29.5% (95% CI, 24.2-34.9) of children with current ASD did not receive either behavioral or medication treatment. Conclusions and Relevance: This study showed that the prevalence of ASD in the United States was relatively high, and it varied substantially across US states. Almost 30% of US children with ASD did not receive behavioral or medication treatment, which calls for a critical need to understand and address the barriers for those children to receive appropriate treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamapediatrics.2018.4208

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 19

  1. Lai, 2014, Autism., Lancet, 383, 896, 10.1016/S0140-6736(13)61539-1 · DOI · Paper page
  2. Modabbernia, Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses, Mol Autism
  3. Geschwind, 2015, Gene hunting in autism spectrum disorder: on the path to precision medicine., Lancet Neurol, 14, 1109, 10.1016/S1474-4422(15)00044-7 · DOI · Paper page
  4. Buescher, 2014, Costs of autism spectrum disorders in the United Kingdom and the United States., JAMA Pediatr, 168, 721, 10.1001/jamapediatrics.2014.210 · DOI · Paper page
  5. Zablotsky, 2015, Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey., Natl Health Stat Report, 1
  6. Blumberg, 2013, Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012., Natl Health Stat Report, 1
  7. Xu, 2018, Prevalence of autism spectrum disorder among US children and adolescents, 2014-2016., JAMA, 319, 81, 10.1001/jama.2017.17812 · DOI · Paper page
  8. Maglione, 2012, Nonmedical interventions for children with ASD: recommended guidelines and further research needs., Pediatrics, 130, S169, 10.1542/peds.2012-0900O · DOI · Paper page
  9. Reichow, 2012, Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)., Cochrane Database Syst Rev, 10, CD009260
  10. Witwer, 2005, Treatment incidence and patterns in children and adolescents with autism spectrum disorders., J Child Adolesc Psychopharmacol, 15, 671, 10.1089/cap.2005.15.671 · DOI
  11. Aman, 2003, Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio., J Autism Dev Disord, 33, 527, 10.1023/A:1025883612879 · DOI · Paper page
  12. Zablotsky, 2017, Estimated prevalence of children with diagnosed developmental disabilities in the United States, 2014-2016., NCHS Data Brief, 1
  13. Ali, 2018, Utilization of mental health services by preschool-aged children with private insurance coverage., Adm Policy Ment Health, 45, 731, 10.1007/s10488-018-0858-x · DOI
  14. Myers, 2007, Management of children with autism spectrum disorders., Pediatrics, 120, 1162, 10.1542/peds.2007-2362 · DOI · Paper page
  15. Orinstein, 2014, Intervention for optimal outcome in children and adolescents with a history of autism., J Dev Behav Pediatr, 35, 247, 10.1097/DBP.0000000000000037 · DOI · Paper page
  16. Levy, 2015, Complementary and alternative medicine treatments for children with autism spectrum disorders., Child Adolesc Psychiatr Clin N Am, 24, 117, 10.1016/j.chc.2014.09.004 · DOI
  17. Salomone, 2015, Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe., Eur J Pediatr, 174, 1277, 10.1007/s00431-015-2531-7 · DOI
  18. Höfer, 2017, Use of complementary and alternative medicine in children and adolescents with autism spectrum disorder: a systematic review., Autism, 21, 387, 10.1177/1362361316646559 · DOI
  19. Weitlauf, 2014, Therapies for Children With Autism Spectrum Disorder: Behavioral Interventions Update

Cited by

See all 212

Metadata

Authors
Xu, G., Strathearn, L., Liu, B., O’Brien, M., Kopelman, T. G., Zhu, J., Snetselaar, L. G., & Bao, W.
Venue
JAMA Pediatrics
Published
2019-02-01
Volume
173
Issue
2
Pages
153
ISSN
  • 1072-4710 (ISSN-L)
  • 2168-6203
OpenAlex
W2903391888
Cited by
212
References
11
FWCI
11.34
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.